News

New cellular and molecular processes underlying communication between gut microbes and brain cells have been described for the first time by scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.

A set of powerful laboratory and computational techniques developed by scientists at Weill Cornell Medicine, the New York Genome Center (NYGC) and the Broad Institute will enable investigators to map the capacity of tumors to develop resistance to drugs and drug combinations. 

In the roughly 100 years since Alois Alzheimer first described the devastating neurodegenerative disease that now bears his name, scientists have developed an increasingly sophisticated understanding of the brain. 

Dr. Hagen Tilgner is exploring how faulty building instructions for brain cells may give rise to depression, schizophrenia, Alzheimer’s disease and more

Dr. Samie R. Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a Maximizing Investigators’ Research Award (MIRA) from the National Institute of Neurological Disorders and Stroke (NINDS).

Weill Cornell Medicine scientists have built the first 3-D-printed automated synthesis units (ASUs) for producing customized radioactive drugs.

Researchers in Doha and New York are collaborating to explore the Qatari genome.

Dr. Peter Goldstein, a professor of anesthesiology at Weill Cornell Medicine, has been awarded a grant from the National Institutes of Health  for a project to develop a non-opioid, non-addicting medicine for a hard-to-treat form of pain called neuropathic pain.

Dr. Chun-Jun (“C.J.”) Guo has won a Director’s New Innovator Award from the National Institutes of Health for an ambitious project to detail how the hundreds of different bacterial species living in the human gut contribute to human health and disease.

Dr. Simon Scheuring, a professor of physiology and biophysics in anesthesiology at Weill Cornell Medicine has been awarded a prestigious National Institutes of Health Director’s Pioneer Award for a project aimed at solving long-standing mysteries about the structural workings of important proteins.

A set of definitions for distinguishing the severity of bleeding in critically ill children has been developed by a team led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

After extensive data gathering and analysis—plus a worldwide media Frenzy—NASA’s famed Twins Study has begun to yield results.

A novel mechanism that regulates activity in the brain, discovered by Weill Cornell Medicine investigators, may help explain the origins of one common type of dementia.

Cornell Tech and Weill Cornell Medicine have been awarded a Robert Wood Johnson Foundation (RWJF) grant that will fund interdisciplinary research on the role of technology among home health aides caring for adults with heart failure.

Weill Cornell Medicine researchers are working to combat the stark racial disparities in breast cancer outcomes

Smoking can lead to an increased risk of urological cancer, with indicators of prolonged or more intense smoking associated with a higher risk for bladder and kidney cancer-related deaths.

Dr. Laura Alonso has been named chief of the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective Sept. 1. Dr. Alonso will also lead the Joan and Sanford I. Weill Center for Metabolic Health at Weill Cornell Medicine.

The most common type of non-Hodgkin lymphoma depends for its aggressive growth and survival on an enzyme that can be therapeutically targeted with a novel compound developed at Cornell University, scientists at Weill Cornell Medicine and Cornell’s Ithaca campus have discovered.

States that require prescribers to register with and use prescription drug monitoring programs in most clinical circumstances saw notably fewer opioid prescriptions and reduced opioid-related hospital use by Medicaid patients compared to states with weak or no drug monitoring program mandates.

A new study presents a technique to identify viruses and bacteria in the human body and quantify injuries to organs by using dead fragments of DNA, called cell-free DNA, that roam throughout the bloodstream and urine.